Results 241 to 250 of about 115,309 (309)

DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High‐Grade Serous Ovarian Carcinoma

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 5, May 2026.
ABSTRACT Extracellular vesicles (EVs), including exosomes, circulate in body fluids and carry pathological genomic information. High‐grade serous ovarian carcinoma (HGSOC) is the most common subtype of ovarian cancer, characterized predominantly by copy number variations (CNVs).
Ryosuke Uekusa   +17 more
wiley   +1 more source

Hereditary ovarian cancer. [PDF]

open access: yesDiscov Oncol
Jurgiel WA, Panasiuk B, Posmyk R.
europepmc   +1 more source

Histone Modifications in Cardiovascular Disease: Mechanisms and Therapeutic Opportunities

open access: yesMedComm, Volume 7, Issue 5, May 2026.
This graphical abstract summarizes how classical and emerging histone posttranslational modifications (PTMs), together with their chromatin regulators (writers, erasers, and readers), govern major pathobiological programs in cardiovascular disease.
Yu Zheng   +8 more
wiley   +1 more source

Germline <i>BRCA</i> testing in routine clinical practice: a single-center experience. [PDF]

open access: yesPathol Oncol Res
Nikolényi A   +15 more
europepmc   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld   +5 more
wiley   +1 more source

“A Much Needed Specialist Service”: Patient Perspectives on Hereditary Cancer Risk Psychology Service Delivery and Future Service Development

open access: yesPsycho-Oncology, Volume 35, Issue 5, May 2026.
ABSTRACT Objective To evaluate a pilot specialist clinical psychology service for patients who have hereditary risk of breast and ovarian cancer (HBOC). Methods Multi‐method study reviewing 51 patients' demographic data, their engagement with the service and psychological assessment data (PHQ‐9 and GAD‐7).
Sara Scardini   +4 more
wiley   +1 more source

A report of novel inactivating missense mutations of BRCA1 detected in patients with acute myeloid leukemia. [PDF]

open access: yesJ Med Case Rep
Ejaz S   +7 more
europepmc   +1 more source

Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation

open access: yesThe Prostate, Volume 86, Issue 6, Page 727-731, May 2026.
ABSTRACT Background Methyl Methanesulfonate‐Sensitivity Protein 22‐Like (MMS22L) plays a key role in homology‐directed DNA repair, and experimental models have shown that its loss confers sensitivity to Poly (ADP‐ribose) polymerase inhibitors (PARPi).
Mayuko Kanayama   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy